Welcome to this week’s Pandora Report! This issue examines ongoing international efforts to demilitarize Syria’s residual chemical weapons arsenal and seek accountability, community feedback on new U.S. implementation guidance for high-risk life sciences research, and new WHO global training tools on dual-use research oversight.
📢 Interested in Graduate Study in Public Policy, Biodefense, or International Security?
The Schar School of Policy and Government is hosting a series of upcoming Faculty Information Sessions for prospective master’s and graduate certificate students. These interactive sessions offer a direct opportunity to learn about curriculum structure, career pathways in biodefense and policy, and the student experience at George Mason University.
Virtual Briefing: Syria’s Chemical Weapons Legacy – Current Issues and Challenges
Fifteen years after the forces of deposed Syrian dictator Bashar al-Assad used banned nerve agents outside Damascus, killing more than 1,200 people, Syria’s new government and the international community are working to address the deadly legacies of the civil war. The video recording for last week’s briefing on Syria’s Chemical Weapons Legacy: Current Issues and Challenges, moderated by Biodefense Program Director Dr. Gregory Koblentz, is now available online. Hosted in partnership with the Arms Control Association Inc., the panel features expert remarks from Amb. Katoub, former OPCW Director-General Amb. Ahmet Üzümcü, Fadel Abdulghany from the Syrian Network for Human Rights, and Richard Yates, the UK Deputy Permanent Representative to the OPCW on demilitarization, victim support, and accountability. Watch the full recording here.
Closing the Bird Flu Surveillance Gap
By Margeaux Malone, Pandora Report Associate Editor
A recently published study led by Arizona State University professor Matthew Scotch, found that the D1.1 variant of H5N1 clade 2.3.4.4b, the avian influenza strain driving the global bird flu outbreak over the last several years, circulated undetected in North American wild birds for roughly three months before it was first identified in September 2024. By comparing Arizona samples against thousands of viral sequences nationwide, the team traced the virus’s spread in a west-to-east pattern, moving from the Pacific Flyway into the Central, then the Mississippi, and finally the Atlantic, with each region shifting between acting as a source or sink for transmission over the course of the fall migration. Notably, the Arizona samples lack the Q226L mutation linked to a shift toward binding human-type receptors, though Scotch cautioned the virus is still continually evolving. This avian influenza strain has already caused human infections, including the first U.S. death linked to H5N1, in Louisiana in early 2025. Looking ahead to the next migration season, Scotch recommends sequencing unusual detections more rapidly, strengthening genomic surveillance in the weeks before and during migration, and connecting surveillance across wildlife, poultry, and mammals under a unified “One Health” framework, with regions sharing data in real time rather than waiting until infection numbers rise.
Despite the need to strengthen surveillance and rapid data reporting for bird flu, some experts note it is easier said than done. Alveo Technologies is nearing USDA approval for a barn-side test for poultry that delivers results in 45 minutes from a single throat swab. The device uses a chemistry process that skips some of the steps required for PCR and validation reports 100 percent specificity against 12 influenza A strains and 19 non-influenza organisms. Since February 2022, bird flu has hit nearly 2,000 U.S. poultry premises and cost more than 185 million birds. The technology is paired with a predictive tool, UC Davis epidemiologist Maurice Pitesky’s Waterfowl Alert Network, which predicts daily waterfowl abundance around commercial poultry farms using empirical bird flu detections, weather radar, satellite imagery and telemetry. However, accessible detection alone is not the issue, reporting is. Only about 1,500 of the roughly 160,000 farms covered by the Network have opted in, leaving data too coarse to connect individual farm outbreaks to nearby waterfowl activity. Pitesky noted it is a collective-action problem that could be better addressed by giving farms a secure, confidential channel to share their data with researchers and suggests USDA consider withholding indemnity payments from farms that refuse to share.
Further Reading:
- “This isn’t a question of if, it’s a question of when,” Ryan Heath, Politico
- “#NoBirdFlu: EFSA and European Commission announce practical resources to reduce bird flu risk,” European Food Safety Authority
- “H5N1 Spreads Among Australian Wildlife as Flu Season Ramps Up,” Genetic Engineering & Biotechnology News
Crowdsourcing Feedback on US Dual-Use Research Oversight Policy
David Gillum, Research Assistant Professor at Arizona State University, and Rebecca Moritz have developed a preliminary white paper, “A White Paper on Developing Implementation Guidance for the United States Government Policy for Stopping High-Risk Life Sciences Research,” for which they are seeking input from the scientific, biosafety, biosecurity, research compliance, research administration, research security, and broader life sciences communities. The experience of these communities will be important in identifying where federal guidance needs greater clarity, where implementation may be difficult in practice, and where additional tools, examples, or approaches are needed. Their practical input is essential to developing guidance that is scientifically sound, clear, and workable across institutions.
📄 Read the current version of the white paper here. The document is publicly available for viewing. David and Rebecca sincerely welcome proposed edits, additional examples, identification of gaps, alternative approaches, and other substantive comments. Anyone who would like access to comment can email David Gillum at David.Gillum@gmail.com.
WHO Academy Launches Online Training on Dual-Use Research and Responsible Life Sciences
With more than 1000 learners enrolled and 237 certificates awarded, the WHO Academy hosted a basic-level training course titled “Dual-use research and the responsible use of the life sciences,” which is helping professionals worldwide strengthen their understanding of biorisks, dual-use research oversight, and responsible research practices. Designed to be practical and interactive, this course equips researchers, laboratory personnel, policymakers, and regulators across the One Health spectrum with the knowledge and tools needed to identify, assess, and mitigate biorisks while promoting effective governance of dual-use research.
🌐 The course is available free of charge in Arabic, Chinese, English, French, Portuguese, Russian, and Spanish. Participants receive a certificate of completion upon finishing. Learn more and register via the WHO Academy here.
IN OTHER NEWS
AI Governance, Outbreak Response and Global Health
- “Anthropic quietly sets up biology lab as it ramps AI drug program,” Jeffrey Dastin and Michael Erman, Reuters
- “NTI at 25: Fostering Innovation Through Technology Governance,” Jake Jordan, NTI
- “DHS exploring new biosurveillance capabilities as biological threats evolve, officials say,” Edward Graham, Nextgov/FCW
- “Researchers file First Amendment challenge to NIH grant screening,” Jocelyn Kaiser, Science
- “White House drops executive order for tighter NIH purview,” Lia DeGroot, Roll Call
- “How Scientists Contained a Threat That Could Have Destroyed Humanity,” Kate Zerenike, NY Times
- “Fears grow that Ebola could reach DRC capital by the end of the month,” Malcolm Neaum and Hugh Tomlinson, The Observer
- “WHO sees ‘encouraging signs’ in Congo Ebola fight, but warns cases in one eastern region are surging,” Associated Press, The WP
- “Congo begins Ebola vaccinations for health workers in the epicenter of the outbreak,” Constant Same Bagalwa | AP, The WP
- “Why AI Isn’t Likely to Wipe Out Humanity With Bioweapons,” Kate Knibbs and Emily Mullin, Wired
- “Evaluating Superhuman Biological Capabilities,” Shiv Muthupandiyan and SecureBio, Substack
- “Local, state public health officials overwhelmingly faced serious backlash during pandemic, report reveals,” Meghan Holohan, CIDRAP
- “Ebola Is Only the Beginning: Congo’s Warning for the Global Health System,” Stephanie Psaki, Foreign Affairs
- “Nearly 3m more lives could be saved in next pandemic if vaccines are shared more fairly, says report,” Kat Lay, The Guardian
- “$1.3bn in US health funds left unspent by Trump ‘could lead to 150,000 preventable deaths’,” Liz Cookman, The Independent
NEW: Singapore Conference on Mirror Life
Since the December 2024 publication of the Science article, Confronting risks of mirror life, and the associated Technical Report on Mirror Bacteria: Feasibility and Risks, scientific, policy, and other conferences have explored the feasibility and risks of mirror life. Now, nearly two years later, the Singapore Conference on Mirror Life brings together senior experts from Singapore and the broader international community to discuss the policy implications of mirror life.
This webinar will take place on Monday, September 28, 3:00-6:00 AM ET. Learn more and register here.
International Bio-Responsibility Conference 2027
Organized under the Bio-Responsibility Initiative at the Centre for Society and Policy (CSP), the conference brings together people to advance dialogue, build partnerships, and promote safe, secure, and responsible life science research, development, and innovation. The conference will host experts, policymakers, and practitioners around the world to discuss emerging biological risks and ways to strengthen responsible governance.
The deadline to register is September 30. Learn more and register here.
Training Course on ‘Biotechnology Innovation and Biosecurity’
From the International Centre for Genetic Engineering and Biotechnology (ICGEB) and the Biological Weapons Convention Implementation Support Unit: “This training focuses on strengthening capacities in biosecurity, biosafety, and biological risk management in the context of rapid advances in biotechnology with an integrated, interdisciplinary approach to manage biothreats at the intersection of humans, animals, plants and the environment. It addresses the governance, technical, and operational dimensions of preventing, detecting, and responding to biological threats, while promoting responsible and peaceful scientific research and innovation in accordance with article X of the Biological Weapons Convention (BWC).”
This in-person event will be held from October 12-16 in New Delhi, India. Learn more and apply here.
Biomanufacturing for Defense & Security Summit
From Diversified Solutions Incorporated (DSI Groups): “This event will bring together senior thought leaders and stakeholders from across DoW, Military Research Labs, Federal Government, Commercial Industry, & Academia to discuss how each are advancing biomanufacturing to enhance national security objectives, produce critical materials for defense applications, and strengthen the overall U.S. bioindustrial manufacturing base. Biomanufacturing is crucial for U.S. national security because it enables domestic production of critical materials, medicines, and defense supplies, reducing reliance on foreign adversaries, which in turn creates resilient supply chains for the military and economy.”
This event will take place from October 27-28 at the National Harbor, MD. Learn more and register here.
Frontiers in Synthetic Biology: SpudCells, Mirror Life and Societal Implications
From the Consortium on Law and Values: “Advances in cell engineering and synthetic biology offer enormous potential benefits, while raising ethical and policy issues. SpudCell, the first synthetic cell that can grow and reproduce, built from non-living chemicals, was developed by a team at the University of Minnesota. Scientists have cautioned against creating organisms with molecules that are mirror images of the biological components of known life, as existing organisms would have no immune defenses. Join three experts on synthetic biology, biosecurity, and bioethics to explore how to realize the promise of synthetic biology while controlling potential risks.”
This webinar will take place on Thursday, October 29, at 3:00 PM ET. Learn more and register here.
NEW: Director, Global Biological Policy and Programs – Job Opening
From the Nuclear Threat Initiative (NTI): “NTI – a nonprofit, nonpartisan global security organization focused on reducing nuclear, biological, and emerging technology threats imperiling humanity – is seeking a Director to join the Global Biological Policy and Programs team. The NTI | bio team is focused on reducing catastrophic biological risks, and we are working toward this goal by strengthening biotechnology governance; bolstering biosecurity in countries around the world; strengthening international capabilities to uphold the norm against bioweapon development and use; driving progress in Global Health Security; and building the biosecurity field.”
Learn more and submit your application here.
